Jagsonpal Pharmaceuticals

222.03

+17.66 (8.64%) tick

NSE

Buy Sell

NSE BSE

Last updated on 12 May 2025 04:55 PM

Open Demat account

Returns

-10.27%

Loading chart...

Fundamentals

Large Cap

Financial - Banking

Market Cap (Cr)

1356.62

Earning Per Share

8.5

Dividend Yield

1.79%

P/E Ratio

32.92

P/B Ratio

5.65

Debt to Equity

0.04

Performance

min-value

max-value

Open

56,601.30

52-wk High

75,250.00

High

56,601.30

52-wk Low

75,250.00

Low

56,601.30

Band

75,250.00

Lower Circuit

56,601.30

Upper Circuit

75,250.00

Volume

56,601.30

VWAP

75,250.00

52 Week Performance

min-value

max-value

5.34% down side

up side5.34%

About the company

Promoted by Rajpal Singh Kochhar in August, 1978, Jagsonpal Pharmaceuticals Limited is engaged in the manufacture and marketing bulk drugs and pharmaceuticals at its plant at Faridabad in Haryana. The Company has adopted the strategy of clubbing all its products in seven groups for effective marketing and reducing costs. Simultaneously, it has geared up to set up an ultra modern multi-purpose basic drugs and formulation plant through its subsidiary, Jagsonpal Exports India Pvt Ltd. The company has a strategic alliance with Fidia Spa, Italy; and B Spofola, Czechoslovakia; to manufacture sophisticated drugs in India. It has tied up with another Israel-based company, Makhteshim Chemical Works, for acquiring the marketing rights of an anti-oxidant product.

Similar Companies

Laurus Labs

593.45 +4.65 (0.01%) tick

1Yr Returns

+35.98%

Piramal Pharma Limited

212 +4.23 (0.02%) tick

1Yr Returns

+34.74%

Suven Pharmaceuticals

1063.3 -14.50 (-0.01%) tick

1Yr Returns

+62.56%

J.B.Chemicals & Pharma

1557.2 +32.60 (0.02%) tick

1Yr Returns

-14.97%

Wockhardt

1270 +45.70 (0.04%) tick

1Yr Returns

+128.01%